tradingkey.logo
๎™

eXoZymes Inc

EXOZ
12.300USD
+0.100+0.82%
์ข…๊ฐ€ย 12/19, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
103.16M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
๎™

์ž์„ธํ•œ ๋‚ด์šฉ์€ eXoZymes Inc ํšŒ์‚ฌ

eXoZymes Inc, formerly Invizyne Technologies, Inc., is an artificial intelligence (AI) engineered enzyme that can transform sustainable feedstock into essential chemicals, medicines, and biofuels. The Company has developed a platform that offers the tools and insight to control and optimize natureโ€™s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.

eXoZymes Inc ์ •๋ณด

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ EXOZ
ํšŒ์‚ฌ ์ด๋ฆ„eXoZymes Inc
์ƒ์žฅ์ผNov 13, 2024
CEOHeltzen (Michael)
์ง์› ์ˆ˜31
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒNov 13
์ฃผ์†Œ750 Royal Oaks Dr
๋„์‹œMONROVIA
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐ€United States of America
์šฐํŽธ ๋ฒˆํ˜ธ91016
์ „ํ™”16264151488
์›น์‚ฌ์ดํŠธhttps://exozymes.com/
์ข…๋ชฉ ์ฝ”๋“œ EXOZ
์ƒ์žฅ์ผNov 13, 2024
CEOHeltzen (Michael)

eXoZymes Inc์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
646.48K
-3.94%
Mr. Edgardo Rayo
Mr. Edgardo Rayo
Director
Director
77.91K
--
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
16.58K
+6.69%
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
6.98K
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
Dr. James J. (Jim) Lalonde, Ph.D.
Dr. James J. (Jim) Lalonde, Ph.D.
Independent Director
Independent Director
--
--
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Director
Director
--
--
Dr. James U. Bowie, Ph.D.
Dr. James U. Bowie, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lon Edward Bell, Ph.D.
Dr. Lon Edward Bell, Ph.D.
Independent Director
Independent Director
--
--
Dr. Tyler Korman, Ph.D.
Dr. Tyler Korman, Ph.D.
Vice President - Research
Vice President - Research
--
--
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
646.48K
-3.94%
Mr. Edgardo Rayo
Mr. Edgardo Rayo
Director
Director
77.91K
--
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
16.58K
+6.69%
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
6.98K
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
Dr. James J. (Jim) Lalonde, Ph.D.
Dr. James J. (Jim) Lalonde, Ph.D.
Independent Director
Independent Director
--
--

์ˆ˜์ต ๋ถ„์„

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
์‚ฌ์—…๋ณ„
์ง€์—ญ๋ณ„
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ๋ณด์œ  ํ†ต๊ณ„

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Aug 23
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Aug 23
์ฃผ์ฃผ
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
MDB Capital Holdings, LLC
46.87%
Korman (Tyler Ph.D.)
8.68%
Opgenorth (Paul Hideo)
7.71%
Bowie (James U. Ph.D.)
6.89%
Rayo (Edgardo Javier)
0.93%
๊ธฐํƒ€
28.92%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
MDB Capital Holdings, LLC
46.87%
Korman (Tyler Ph.D.)
8.68%
Opgenorth (Paul Hideo)
7.71%
Bowie (James U. Ph.D.)
6.89%
Rayo (Edgardo Javier)
0.93%
๊ธฐํƒ€
28.92%
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
๋น„์œจ
Corporation
46.87%
Individual Investor
24.86%
Investment Advisor
0.44%
Investment Advisor/Hedge Fund
0.28%
๊ธฐํƒ€
27.55%

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Dec 8
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Dec 8
๋ณด๊ณ  ๊ธฐ๊ฐ„
๊ธฐ๊ด€ ์ˆ˜
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
2025Q4
11
75.38K
0.94%
--
2025Q3
11
75.38K
0.94%
--
2025Q2
11
75.38K
0.94%
-1.39K
2025Q1
9
76.77K
1.17%
-21.33K
2024Q4
7
98.10K
0.00%
+98.10K

์ฃผ์ฃผ ํ™œ๋™

๎™Œ
์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
Chg %
๋‚ ์งœ
MDB Capital Holdings, LLC
3.93M
46.87%
--
--
Jun 09, 2025
Korman (Tyler Ph.D.)
728.28K
8.68%
-28.65K
-3.78%
Jun 16, 2025
Opgenorth (Paul Hideo)
646.48K
7.71%
-26.48K
-3.94%
Jun 13, 2025
Bowie (James U. Ph.D.)
577.91K
6.89%
--
--
Jun 09, 2025
Rayo (Edgardo Javier)
77.91K
0.93%
--
--
Jun 09, 2025
The Vanguard Group, Inc.
23.15K
0.28%
-27.22K
-54.03%
Jun 30, 2025
Geode Capital Management, L.L.C.
20.60K
0.25%
+3.00
+0.01%
Jun 30, 2025
Lalonde (James Joseph)
18.87K
0.23%
-174.00
-0.91%
Jun 09, 2025
Heltzen (Michael)
16.58K
0.2%
+1.04K
+6.69%
Jul 02, 2025
Bell (Lon E)
12.12K
0.14%
+12.12K
--
Jun 09, 2025
๋” ๋ณด๊ธฐ

๊ด€๋ จ ETF

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
์ด๋ฆ„
๋น„์œจ
iShares Micro-Cap ETF
0.01%
iShares Micro-Cap ETF
๋น„์œจ0.01%

์ฃผ์‹ ๋ฐฐ๋‹น๊ธˆ

๎™Œ
์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ด 0.00 USD์˜ ๋ฐฐ๋‹น๊ธˆ์ด ๋ถ„๋ฐฐ๋˜์—ˆ์Šต๋‹ˆ๋‹ค.
๋‚ ์งœ
๋ฐฐ๋‹น๊ธˆ
๊ธฐ์ค€์ผ
์ง€๊ธ‰์ผ
๋ฐฐ๋‹น๋ฝ์ผ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ถ„ํ• 

๎™Œ
๋‚ ์งœ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
๋‚ ์งœ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

eXoZymes Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋ˆ„๊ตฌ์ธ๊ฐ€์š”?

๎™Œ
eXoZymes Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์Šต๋‹ˆ๋‹ค:
MDB Capital Holdings, LLC๋Š” 3.93M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 46.87%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Korman (Tyler Ph.D.)๋Š” 728.28K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 8.68%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Opgenorth (Paul Hideo)๋Š” 646.48K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 7.71%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Bowie (James U. Ph.D.)๋Š” 577.91K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 6.89%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Rayo (Edgardo Javier)๋Š” 77.91K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 0.93%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.

eXoZymes Inc์˜ ์ƒ์œ„ 3๋Œ€ ์ฃผ์ฃผ ์œ ํ˜•์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
eXoZymes Inc์˜ ์ฃผ์š” ์ฃผ์ฃผ ์œ ํ˜• ์ƒ์œ„ 3๊ฐ€์ง€๋Š”
MDB Capital Holdings, LLC
Korman (Tyler Ph.D.)
Opgenorth (Paul Hideo)์ž…๋‹ˆ๋‹ค.

eXoZymes Inc(EXOZ)์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ๋ช‡ ๊ฐœ์ž…๋‹ˆ๊นŒ?

๎™Œ
2025Q4 ๊ธฐ์ค€์œผ๋กœ, eXoZymes Inc์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ์ด 11๊ณณ์ด๋ฉฐ, ์ด๋“ค์ด ๋ณด์œ ํ•œ ์ฃผ์‹์˜ ์ด ๊ฐ€์น˜๋Š” ์•ฝ 75.38K๋กœ ์ „์ฒด ๋ฐœํ–‰ ์ฃผ์‹์˜ 0.94%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค. ์ด๋Š” 2025Q3 ๋Œ€๋น„ -- ์ฆ๊ฐ€ํ•œ ์ˆ˜์น˜์ž…๋‹ˆ๋‹ค.

eXoZymes Inc์˜ ์ตœ๋Œ€ ์ˆ˜์ต์›์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
-- ๊ธฐ์ค€, eXoZymes Inc์˜ -- ๋ถ€๋ฌธ์ด ๊ฐ€์žฅ ๋†’์€ ๋งค์ถœ์„ ๊ธฐ๋กํ–ˆ์œผ๋ฉฐ, ๊ธˆ์•ก์€ --๋กœ ์ „์ฒด ๋งค์ถœ์˜ --%๋ฅผ ์ฐจ์ง€ํ–ˆ์Šต๋‹ˆ๋‹ค.
KeyAI
๎™